Starbucks said growth in stores open at least 13 months was much better than expected —…
SYND
Medicare is about to start negotiating the prices of some medications administered by doctors
Jaimy Lee Jaimy Lee is a healthcare reporter and editor for MarketWatch. She is based in…
This top stock-picker spotted Nvidia and GLP-1s early — and made over 200%. Here’s what he’s buying now.
Citrini Research founder James Van Geelen identifies potential big money trends and stakes his claim far…
Why this hedge-fund veteran says investors should own both high-flying gold and the sinking U.S. dollar
Published: Jan. 28, 2026 at 7:00 a.m. ET The year is starting to look like hell in…
How both sides of the ‘Sell America’ debate can be right
There are two opposing views of whether the so-called “sell America” trade is happening.
Despite questions about AI’s long-term profitability, OpenAI and Anthropic accelerate investment
OpenAI’s latest funding round suggests a valuation of up to $830 billion, while Anthropic’s implies $350…
This Intel executive bought the dip as the stock sank on earnings disappointment
Published: Jan. 28, 2026 at 4:07 a.m. ET Intel CFO David Zinsner is putting some of his…
These stocks are the market’s new momentum plays as Big Tech loses steam
Michael Brush Michael Brush is a columnist for MarketWatch. He is the publisher of the stock…